
was one of the first investors in the cannabis industry in the United States; today he is celebrated in the mainstream and biopharmaceutical media as an international authority on the development of large-scale cannabis infrastructure around the world and the most advanced pharmaceutical cannabinoid products. Mr. Sassano is also respected for his successful predictions of long-term cannabis market trends and movements, which he generously shares in many forums. He is known for leading a merger of the cannabis cultivation company Solaris Farms, which he founded and operated, with The Sanctuary. In recent years, Michael has shifted his focus to his role as CEO and Chairman of the Board of SOMAÍ Pharmaceuticals, a leading EU GMP-compliant, vertically integrated, multi-country operator (MCO) company with a global distribution presence for the largest and most advanced EU GMP-certified cannabinoid pharmaceutical extract portfolio. Michael Sassano’s primary goal for SOMAÍ is to build a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics.